Last update:
An Australian court found Thursday that Johnson & Johnson was "negligent" in supplying thousands of women pelvic meshes without adequate testing or health warnings, a ruling that exposes the firm to millions of dollars in ...
2 hours ago
2
0
About 10% of the world population suffers from migraine headaches, according to the National Institute of Neurological Disorders and Stroke. To alleviate migraine pain, people are commonly treated with opioids. But, while ...
17 hours ago
0
4
Every day, more than 100 Americans lose their lives to the opioid crisis, and researchers from across the nation are racing to find solutions. One of the latest strategies—a cascade of care model for the State of Rhode ...
17 hours ago
0
11
Researchers at the University of Alberta have discovered a new class of drugs with the potential to make cancer treatment safer and more effective by preventing cancer cells from repairing themselves.
22 hours ago
0
12
Thousands of lawsuits across the United States have accused a drug company owned by the billionaire Sackler family of using false claims to push highly addictive opioids on an unsuspecting nation, fueling the deadliest drug ...
Nov 20, 2019
0
2
(HealthDay)—Migraine sufferers who cannot get relief from existing medications may soon have a novel treatment option, a new trial suggests.
Nov 19, 2019
1
37
(HealthDay)—The generic valsartan recall has had population-level impacts on patients in Ontario, Canada, according to a research letter published online Nov. 11 in Circulation to coincide with the annual meeting of the ...
Nov 18, 2019
0
2
(HealthDay)—A cheap drug that's been around for centuries as a gout treatment might also shield heart attack survivors from future heart crises, new trial results show.
Nov 18, 2019
0
12
Scientists at the Institute of Pharmacy at Martin Luther University Halle-Wittenberg (MLU) have developed new delivery vehicles for future gene therapies. A team of researchers led by Dr. Christian Wölk are using artificial ...
Nov 18, 2019
0
3
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum ...
Nov 18, 2019
0
10
Knowledge and awareness of antibiotic resistance and related issues is generally high among European healthcare workers, according to the first European survey to examine attitudes and behaviours in relation to antibiotic ...
Nov 18, 2019
0
0
Stigma and safety fears have made daily dose tapering of opioid prescriptions more common. New research from UC Davis Health physicians, however, shows tapering can occur at rates as much as six times higher than recommended, ...
Nov 18, 2019
1
16
National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression. Elia Acevedo-Diaz, M.D., Carlos Zarate, M.D., ...
Nov 18, 2019
0
3
Approved use of the prescription-strength fish oil drug Vascepa should be widened to include more patients at risk for heart attack and stroke, a U.S. Food and Drug Administration advisory panel recommended Thursday.
Nov 18, 2019
0
3
Dollar Tree has been sent a warning letter for selling over-the-counter (OTC) drugs made by foreign companies with serious, multiple violations of federal manufacturing laws, the U.S. Food and Drug Administration says.
Nov 18, 2019
0
5
Survival for patients with the most common forms of advanced breast cancer could be substantially improved if both younger and older patients had access to a group of anti-cancer drugs called CDK4/6 inhibitors, according ...
Nov 18, 2019
1
3
A parasite is an organism that lives in or on an organism of another species.
Nov 18, 2019
0
0
New drugs can be developed from old ones. This revolutionary pharmacological approach was confirmed by a study published today in Nature Communications that was conducted by two major research centers of the University of ...
Nov 18, 2019
0
4
An Oklahoma judge who had ordered Johnson & Johnson to pay $572 million for its role in the opioid crisis on Friday reduced the figure to $465 million, after a miscalculation.
Nov 16, 2019
1
5
3 hours ago
